[EN] PHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT<br/>[FR] COMPOSITION PHARMACEUTIQUE CONTENANT DES COMPLEXES CYCLOMÉTALLÉS DE CARBÈNES N-HÉTÉROCYCLIQUES POUR LE TRAITEMENT DU CANCER
申请人:UNIV HONG KONG
公开号:WO2011050574A1
公开(公告)日:2011-05-05
The present invention discloses a pharmaceutical composition for treating cancers, comprising a cyclometalated N-heterocyclic carbene complex. Said cyclometalated N-heterocyclic carbene complex contains a gold (III) or platinum (II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.